SHEA works with international organizations is a variety of ways, including endorsement of international conferences in support of SHEA's mission.  SHEA has limited funds set aside to provide speakers for some events.  Content endorsement is also possible upon review by appropriate SHEA committees.  We are always looking for ways to work with international partners. If you have an idea that is not covered by this form, please reach out for consideration by our external affairs committee and SHEA staff. 

For 2018 the deadlines are as follows:

  • Applications Due January 1, 2018 for events held between March 1, 2018 and August 31, 2018.
  • Applications Due June 1, 2018 for events held between September 1, 2018 and February 28, 2019.

Endorsement Applications are based on the merit of the meeting and alignment with SHEA's mission. Questions? Email info@shea-online.org

July 6, 7, 8, 2017
Alpert Medical School Brown University
222 Richmond St.
Providence, RI 02903


Questions? Contact heicfellowscourse@gmail.com

 

In partnership with the Course Directors from:

                            



Perelman School of Medicine                

 

Endorsed by:

SHEA

 

Course Overview
At its inception more than two decades ago, the course was a small and simple collaboration of field experts and their own trainees. Now in its 21st year, the course has gained national renown and attracts participants from all across the United States. This three-day training course offers an interactive series of sessions on basic healthcare epidemiology, infection prevention strategies, healthcare-associated infections and problem pathogens. This course includes didactic lectures and panel discussions with world-renowned faculty from various specialties. The course meets requirements for Infectious Disease fellows for course work in healthcare epidemiology and infection prevention as outlined by the American Board for Internal Medicine.

Learning Objectives

  • Review the epidemiology and risk factors for developing healthcare-associated colonization and infection
  • Review the evidence supporting commonly utilized infection prevention and control strategies for healthcare-associated infections and antibiotic stewardship programs
  • Effectively respond to questions about exposure to communicable diseases and appropriate prevention and control strategies for healthcare associated infections
  • Understand the impact that healthcare-associated infections and antimicrobial resistance play in patient safety
  • List strategies that are effective in mitigating healthcare-associated infections and antimicrobial resistance
  • Discuss and review the career opportunities in healthcare epidemiology and antibiotic stewardship

Who Should Attend
Physicians and other healthcare providers, including Infectious Diseases, Pulmonary, and Critical Care fellows, residents, and other practitioners interested in healthcare-associated infections and antimicrobial resistance. Sponsors may also find attending the course beneficial, ensuring interaction with the rising cadre of practitioners in infectious diseases.

Registration Fee
Registration opens on April 1, 2017 and closes on June 30, 2017. Early bird prices end on June 1, 2017. Prices will be announced during early March. For more information and to register, visit heicfellowscourse.com.

SHEA Podcast Series

Stewardship: Practical Approaches and Applications
(Ripped from the Hallways)

Focusing Stewardship to Help Tackle CDI
How to impact CDAD rates by antimicrobial stewardship (ASP) activities

Panelists

Libby S. Dodds-Ashley, PharmD, MHS Duke University School of Medicine
Larissa May, MD, MSHS, MSPH UC Davis Health System
 
 

 

Focusing Stewardship
Changing the Culture of Culturing

Panelists

James Lewis, PharmD, FIDSA Oregon Health & Science University
Julia E. Szymczak, PhD University of Pennsylvania
 
 

 

Focusing Stewardship
The Big Picture on UTI

Panelists

Susan E. Coffin, MD, MPH Children's Hospital of Philadelphia
Chris Crnich, MD, PhD, MS William S. Middleton VA Hospital

More Podcasts Coming Soon....

 

SAVE THE DATE May 18-21, 2016 • Westin Peachtree • Atlanta, GA More information coming soon!

Past Meetings 

SHEA Spring 2016 Conference
May 18-21, 2016
Atlanta, GA


SHEA Spring 2015 Conference
May 14-17, 2015
Orlando, FL

Antimicrobial Stewardship Conference
February 2-3, 2015
Los Angeles, CA

IDWeek 2014 – SHEA, IDSA, PIDS, HIVMA Scientific Meeting
October 8-12, 2014
Philadelphia, PA

SHEA Spring 2014 Conference
April 3-6, 2014
Denver, CO

17th Annual Fellows Course in Hospital Epidemiology & Infection Control
July 7-9, 2013
Baltimore, MD

SHEA Spring 2013 Conference
May 1-4, 2031
Atlanta, GA

IDWeek 2012 – SHEA, IDSA, PIDS, HIVMA Scientific Meeting
October 17-21, 2012  
San Diego, CA

16th Annual Fellows Course in Hospital Epidemiology & Infection Control
July 5-7, 2012
Johns Hopkins University School of Medicine, Baltimore, MD

SHEA Spring 2012 Conference: Advancing Healthcare Epidemiology and Antimicrobial Stewardship
April 13-16, 2012
Jacksonville, Florida


15th Annual Fellows Course in Hospital Epidemiology & Infection Control
July 6 - 8, 2011
Johns Hopkins University School of Medicine, Baltimore, MD

SHEA-CDC Training Course in Healthcare Epidemiology
May 14-17, 2011
Sheraton Salt Lake City Hotel, Salt Lake City, Utah

21st Annual Scientific Meeting
April 1-4, 2011
Hilton Anatole, Dallas, Texas
Abstracts

Fifth Decennial International Conference on Healthcare-Associated Infections
Co-organized by SHEA, CDC, APIC, and IDSA
March 18-22, 2010
Atlanta, GA
Abstracts

19th Annual Scientific Meeting
March 19-22, 2009
San Diego, CA 

18th Annual Scientific Meeting
April 5-8, 2008
Orlando, FL

17th Annual Scientific Meeting
April 9-12, 2007
Baltimore, MD

Contact info@shea-online.org for information about:

  • Scientific meetings 1990-2010
  • Abstracts 
  • CME 

CME Credit for ICHE Reviewers

  • ICHE Editors invite you to become a reviewer and earn CME.
  • Already a reviewer? Earn credit easily while completing your next review.
  • Interested in becoming a Reviewer? Find out how below!

CME Credit Guidelines for ICHE Manuscript Reviewers

Needs Assessment Statement

The Society of Healthcare Epidemiology of America (SHEA) has a responsibility to maintain an ongoing knowledge and understanding of the most current issues in healthcare epidemiology and infection prevention, thus ensuring physicians and other healthcare practitioners are providing the highest standards of patient care. One method of maintaining that standard is through the manuscript review process. Review of manuscripts being considered for publication in SHEA’s journal Infection Control and Hospital Epidemiology (ICHE) provides a platform for reviewers to refine their skills in performing critical analysis of the literature. Such review ultimately increases the quality of the published science by ensuring assessment based on expert perspectives from practice and via a mechanism free from conflict of interest.

Target Audience

The target audience is physicians in clinical practice, research and public health, who are active in multidisciplinary fields, including infectious disease, internal medicine, healthcare epidemiology, microbiology, and pediatrics.

Learner Objectives

Upon completion of this CME activity, participants will be able to:

  • Demonstrate skills in performing critical analyses of the medical literature and knowledge of current issues and developments in epidemiology and infection prevention.
  • Conduct an appropriate review of the literature related to the proposed manuscript and, when available, a review of the evidence-based clinical data related to the proposed manuscript.
  • Prepare a confidential review without conflict of interest.
  • Produce a standardized, concise, constructive and timely evaluation that is balanced and objective avoiding any personal comments.
  • Synthesize the review of literature with a thorough review of the proposed manuscript thereby identifying its strengths and areas needing improvement prior to publication.

Accreditation Statement

The Society of Healthcare Epidemiology of America (SHEA) is accredited by the Accreditation Council on Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SHEA designates this manuscript review activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™ with a maximum of 15 credits per year. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Information

In compliance with ACCME’s Standards for Commercial Support of Continuing Medical Education, anyone in a position to influence content is required to disclose any real or apparent conflicts of interest relating to the topics addressed in this meeting. On the basis of disclosed information, SHEA identifies and resolves all conflicts of interest before delivery of content. Presenters are also required to disclose any mention of off-label or unapproved uses of drugs or devices.

Editor-in-Chief

Suzanne F. Bradley, MD

  • Advisory/Consultant Role: Glaxo
  • Investigator: Pfizer 
  • Research Grants: Various VA 

Deputy Editor

Carol Chenoweth, MD

  • No financial relationships to report.

Managing Editor

VACANT

Associate Editor(s)

David Calfee, MD, MS

  • Pending

Lindsay Nicolle, MD

  • No financial relationships to report.

Trevor Van Schooneveld, MD

  • Speaker Honoraria - Roche
  • Research Grants: Rebiotrix & Merck

David Weber, MD, MPH

  • Expert Testimony: Ethicon
  • Advisory/Consultant Role: Merck, Pfizer, Germitec
  • Speaker Honoraria: Merck, Pfizer

Measured Outcomes (Knowledge)

Results are measured through learner self-report in the activity evaluation and through objective observation by the supervising associate editors who assure the review meets CME requirements.

Content Validation Statement

The Society for Healthcare Epidemiology of America accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements with regard to any recommendations for clinical care. All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contradictions in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Responsibility of the Editors

The Editor-in-Chief directs and supervises the policies of the ICHE journal and is responsible for maintaining its scientific and literary quality. The Editor-in-Chief and the Associate Editors are responsible for ensuring that all authors receive confidential, expert, critical, and unbiased reviews of their work in a timely fashion. The editors and members of the editor's staff should not disclose any information about a manuscript submitted for review to anyone except the reviewers or authors or those working on their behalf.

Responsibility of the Reviewers

The critical and confidential review of manuscripts is an essential element of research publications. Among the obligations of reviewers is the commitment to providing an expert, critical, and constructive scientific and literary appraisal of research reports in their fields of knowledge, skills, and experience in a fair and unbiased manner. In order to facilitate the prompt sharing of scientific results, it is also the obligation of each reviewer to complete their assignments promptly, within the editor's deadline.

Interested in becoming a Reviewer?

Please contact Kristy Weinshel at kweinshel@shea-online.org.

 

The SHEA International Ambassadors Program

SHEA currently is accepting applications for the 2018 International Ambassadors Program until **DEADLINE EXTENDED** December 15, 2017.  For more information, please visit the links below or email ambassadors@shea-online.org.

Overview

Since 2009, SHEA has partnered with 3M to benefit the international community of healthcare professionals dedicated to infection prevention through our International Ambassadors Program. The program is dedicated to building collaborative relationships between U.S. and international healthcare professionals with expertise in healthcare epidemiology and infection prevention.

In 2015, this program was updated to allow more Ambassadors to benefit from exposure to large US conferences dedicated to infection prevention and control. Selected ambassadors will attend the SHEA 2017 Spring Conference in St. Louis, Missouri for training and will receive a one-year membership with SHEA to foster networking opportunities and expose them to SHEA's journal and other educational opportunities that can promote knowledge dissemination. A total of 18 Ambassadors will be selected in 2018 and provided a $3,000 travel grant to assist with the costs of attending the meeting.

Response to the International Ambassadors Program has been noteworthy since its inception: over 425 applicants from around the world have sought a place in this elite group. SHEA has welcomed seventy-nine Ambassadors representing thirty-seven countries: Argentina, Bangladesh, Barbados, Brazil, Chile, China, Colombia, Egypt, Ethiopia, Ecuador, Ghana, Greece, Hungary, India, Ireland, Israel, Jamaica, Japan, Kenya, Korea, Lebanon, Malaysia, Mexico, Moldova, Morocco, Namibia, Nepal, Nigeria, Pakistan, Papua New Guinea, Philippines, Singapore, South Africa, Sudan, Thailand, Togo, and Vietnam.

 

 

Sponsorship

SHEA gratefully acknowledges the financial generosity of 3M Corporation, which supports the International Ambassadors Program.

2017 Delegation

  • Mohammad Ashraful Alam, MBBS, M.PHIL, PhD, Institute of Epidemiology, Disease Control & Research, (IEDCR) (Bangladesh)
  • Ana Belen Arauz-Rodriguez, MD, Hospital Santo Tomas (Panama)
  • Erika Britz, MBChB, MPH, National Institute for Communicable Diseases (South Africa)
  • Yuho Horikoshi, MD, Tokyo Metropolitan Children's Medical Center (Japan)
  • Md. Saiful Islam, MSS, MPH, International Centre for Diarrhoeal Disease Research, Bangladesh, ICDDR,B (Bangladesh)
  • Jiajia Jiang, Medicane Master, Affiliated AoYang Hospital of Jiangsu University  (China)
  • JaHyun Kang, PhD, MPH, Seoul National University, College of Nursing (Republic of Korea)
  • Nagwa Khamis, MD, Cancer Children Hospital of Egypt - 57357 (Egypt)
  • Andie Sunghe Lee, MBBS, DTM&H, MSc, Royal Prince Alfred Hospital (Australia)
  • Madonna Matar, MD, MPH, Notre Dame de Secours University Hospital (Lebanon)
  • Maurice Murugu Mbogori, BSN, Infection Prevention Network -Kenya (Kenya)
  • Keita Morikane, MD, PhD, Yamagata University Hospital  (Japan)
  • Joyce Wamiru Mwangi, KRN/KRM, The Nairobi Hospital (Kenya)
  • Awa Ndir, PhD, Pasteur Institute of Dakar (Senegal)
  • Anusha Rohit, MD, (Microbiology), The Madras Medical Mission (India)
  • Philip Russo, PhD, Deakin University (Australia)
  • Manoj Kumar Sah, MSc Clinical Microbiology, Kantipur Dental College Teaching Hospital & Research Center (Nepal)
  • Shichao Zhu, Master, Infection Control Department of West China Hospital, Sichuan University  (China)

Outcomes

The impact of this program within the Ambassadors' regions as well as for SHEA's international network is significant and continues to evolve. Ambassadors have organized training courses and educational meetings addressing infection prevention and control and antimicrobial stewardship in India, China, Brazil, and the Philippines. Ambassadors have collaborated on a variety of projects, including: outbreak investigation (India), educational programs (India; Philippines), development of professional networks within a country (Kenya), and research. Several ambassadors were even highlighted in a textbook, Best Practices in Infection Prevention and Control: An International Perspective, Second Edition, published jointly with SHEA and Joint Commission International.

International Ambassadors Program Goals in 2018

  • Expand international representation of emerging leaders with a potential for influence in epidemiology in in order to positively impact infection prevention on a global scale.
  • Build collaborative relationships between SHEA members and professionals in infection prevention and healthcare epidemiology that are sustainable and mutually beneficial relationships.
  • Expose participants to the latest scientific content, research and expertise related to infection prevention.
  • Introduce ambassadors to leading industry vendors that serve this market in order to facilitate access to suppliers and partners to ultimately improve quality of care.

Past Delegations

Click here to view a complete list of Delegations

 

International Conference Endorsement Requests

Primer on Healthcare Epidemiology, Infection Control & Antimicrobial Stewardship: Online ID Fellows Course (Available Early 2015!)

Introduction:

This online educational course offers any Infectious Diseases practitioner an opportunity to learn the basics of healthcare epidemiology, infection control and antimicrobial stewardship. Written by adult and pediatric experts in the field, case-based information is presented in a dynamic and interactive learning environment intended to highlight the role of the healthcare epidemiologist. Topics covered include pathogen transmission, outbreak management in the healthcare setting, approach to control of bioterrorism agents, advanced occupational health management, implementing antimicrobial stewardship and the prevention and management of multidrug resistant organisms including Clostridium difficile, surgical site infections and device-associated infections. This is a product of the membership of the Society of Healthcare Epidemiology of America and is endorsed by Infectious Disease Society of America (IDSA) and Pediatric Infectious Disease Society (PIDS).

Overall Learning Objectives:

At the end of this course, the learner will be able to:

  • Describe the role of the healthcare epidemiologist.
  • Analyze when to involve the healthcare epidemiologist and infection control experts - specifically during outbreaks, bioterrorism threats and advanced topics in occupational health management.
  • Discuss how to implement principles of antimicrobial stewardship.
  • Define the epidemiology, surveillance and prevention of healthcare-associated infections including multidrug resistant organisms including Clostridium difficile, surgical site infections and device-associated infections.

Target Audience:

This course was developed for the Infectious Diseases Fellow, but could be useful for other physicians or healthcare practitioners interested in increasing and solidifying their understanding of healthcare epidemiology, infection control and antimicrobial stewardship.

Accreditation Statement:

The Society for Healthcare Epidemiology of America is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SHEA is considered by educators, employers, and leaders in the field to be the gold standard for training in healthcare epidemiology and advancing the practice of infection prevention worldwide. The Society advances professional learning through its annual meeting, workshops, courses, symposium, and web-based learning.

SHEA has several key educational options for people seeking the latest research, skill-building, and networking opportunities in infection prevention and healthcare epidemiology:   

 

International Conference Endorsement Requests

2017 Delegation

  • Mohammad Ashraful Alam, MBBS, M.PHIL, PhD, Institute of Epidemiology, Disease Control & Research, (IEDCR) (Bangladesh)
  • Ana Belen Arauz-Rodriguez, MD, Hospital Santo Tomas (Panama)
  • Erika Britz, MBChB, MPH, National Institute for Communicable Diseases (South Africa)
  • Yuho Horikoshi, MD, Tokyo Metropolitan Children's Medical Center (Japan)
  • Md. Saiful Islam, MSS, MPH, International Centre for Diarrhoeal Disease Research, Bangladesh, ICDDR,B (Bangladesh)
  • Jiajia Jiang, Medicane Master, Affiliated AoYang Hospital of Jiangsu University  (China)
  • JaHyun Kang, PhD, MPH, Seoul National University, College of Nursing (Republic of Korea)
  • Nagwa Khamis, MD, Cancer Children Hospital of Egypt - 57357 (Egypt)
  • Andie Sunghe Lee, MBBS, DTM&H, MSc, Royal Prince Alfred Hospital (Australia)
  • Madonna Matar, MD, MPH, Notre Dame de Secours University Hospital (Lebanon)
  • Maurice Murugu Mbogori, BSN, Infection Prevention Network -Kenya (Kenya)
  • Keita Morikane, MD, PhD, Yamagata University Hospital  (Japan)
  • Joyce Wamiru Mwangi, KRN/KRM, The Nairobi Hospital (Kenya)
  • Awa Ndir, PhD, Pasteur Institute of Dakar (Senegal)
  • Anusha Rohit, MD, (Microbiology), The Madras Medical Mission (India)
  • Philip Russo, PhD, Deakin University (Australia)
  • Manoj Kumar Sah, MSc Clinical Microbiology, Kantipur Dental College Teaching Hospital & Research Center (Nepal)
  • Shichao Zhu, Master, Infection Control Department of West China Hospital, Sichuan University  (China)

2016 Delegation

  • Wensen Chen, MPH, MBBS, Jiangsu Province Hospital (China)
  • Vandana Kalwaje Eshwara, PGDEPI, MD, MBBS, Kasturba Medical College (India)
  • Corey Forde, DM, MBBS, Queen Elizabeth Hospital (Barbados)
  • Jan Gralton, PhD, Clinical Excellence Commission (Australia)
  • Ahmed Mohammed Hakawi, MD, King Fahad Medical City (Saudi Arabia)
  • Joost Hopman, DTMH, MD, Radboud University Medical Center (Netherlands)
  • Aamer Ikram FRCPath(UK), FRCP(Edin), MCPS, FCPS(Microbiology), RBP, MBBS, PhD, Armed Forces Institute of Pathology (Pakistan)
  • Susan Jain, Prince of Wales Hospita (Australia)
  • Elie Kasindi Kabululu, Centre Medical Evangelique De Nyankunde A Beni, Democratic of Republic of Congo
  • Uday Kelkar, Diploma in Management, MD, MBBS, Central Government Health Scheme, Govt of India. (India)
  • Thana Khawcharoenporn, MSc, MD, Thammasat University (Thailand)
  • Reginaldo Adalberto Luz, MSN, RN, Santa Casa de Sao Paulo School of Medical Sciences (Brazil)
  • Sujan Babu Marahatta, PhD, Manmohan Memorial Institute of Health Sciences (Nepal)
  • Nathlee McMorris, MSc, DM, MD, MBBS, National Public Health Laboratory (Jamaica)
  • Mbogori Maurice Murugu, BSN & PH, Infection Prevention Network Kenya (Kenya)
  • Philip Olayiwola Oshun, FMCPath, MPH, MBBS, Lagos University Teaching Hospital (Nigeria)
  • Fu Qiao, MD, West China Hospital, Sichuan University (China)
  • Ratna Rao, CIC, MD, Apollo Hospital, Hyderabad (India)

2015 Delegation

  • Mervat G. Elanany, MD, Cairo University (Egypt)
  • Jaffar A. Al-Tawfiq, MD, Johns Hopkins Aramco Healthcare (Kingdom of Saudi Arabia)
  • Nicolo Andrei A. Anonuevo, MAN, RN, Asian Hospital and Medical Center (Philippines)
  • Ibidunni O. Bode-Sojobi, MBBS, FWACP, Lagos University Teaching Hospital (Nigeria)
  • Elaine Cloutman-Green, PhD, Great Ormond Street Hospital (United Kingdom)
  • Takanori Funaki, MD, National Center for Child Health and Development (Japan)
  • Maojun Ge, MBBS, PhD, Shuguang Hospital Shanghai Traditional Chinese Medicine University (China)
  • Zeinab M.M. Hassan, PhD, The Hashemite University (Jordan)
  • Kayoko Hayakawa, MD, PhD, National Center for Global Health and Medicine (Japan)
  • Milagros M. Herrera, MD, MPH, Hospital Dr. Rafael Estevez (Panama)
  • Khetam Hussein, MD, Rambam Healthcare Campus (Israel)
  • Namita Jaggi, MD, MBBS, Artemis Hospital (India)
  • Shambhu Dutta Joshi, FAM, MD, MBBS, Far West Community Hospital (Nepal)
  • Lesley Lewis, BN, CICP, Northeast Health Wangaratta (Australia)
  • Daniel Ondari Mogeni, BA, CM, Kenya Medical Research Institute (KEMRI) (Kenya)
  • Adebola T. Olayinka, MD, MPH, FMCPath, Ahmadu Bello University Teaching Hospital (Nigeria)
  • Anup Radhakrishna Warrier, DNB, CTH, CIC, MBBS, Aster Medcity (India)
  • Bassim Zayed, MBChB, MPH, Infection Prevention & Control Department, Ministry of Health (Oman)

2014 Delegation

  • Debora Mello, MSN, RN, Coordenação de Vigilância em Saúde (São Paulo, Brazil)
  • Workeabeba Abebe Taye, MD, MPH, School of Medicine, Addis Ababa University (Addis Ababa, Ethiopia )
  • Carmen Soria Segarra, MD, Hospital Luis Vernaza (Guayaquil, Ecuador)
  • Nadeem Masih, RN, Shaukat Khanum Memorial Cancer Hospital Research Centre (Lahore, Pakistan)
  • Majesté Ihou Wateba, MD, University of Lomé (Lomé, Togo)
  • Nagwa Mustafa El Amin, MD, PhD, Soba University Hospital (Al Kharţūm, Sudan)
  • Savitha Nagaraj,MBBS, MD, DNB, St. Johns Medical College and Hospital (Bangalore, India)
  • Fredrick Wambu, RN, Nairobi Hospital (Nairobi, Kenya)
  • Indumathi Venkatachalam, MPH, MBBS, National University Health System, Singapore (Singapore)
  • Diana Vilar-Compte, MD, MSc, Instituto Nacional de Cancerología (Mexico City, Mexico)

2013 Delegation

  • Regina Berba, MD, MSc, Philippine General Hospital (Manila, Philippines)
  • Angela Dramowski, MBChB, FCPaed, MMed, Stellenbosch University (Cape Town, South Africa)
  • Stela Gheorghita, MD, PhD, National Center of Public Health (Chisinau, Republic of Moldova)
  • Ágnes Hajdu, MD, National Center for Epidemiology (Budapest, Hungary)
  • Mohammad Mushtuq Husain, MBBS, DAND, MPhil, PhD, Institute Of Epidemiology, Disease Control & Research (Dhaka, Bangladesh)
  • Basudha Khanal, MBBS, MD, BP Koirala Institute Of Health Sciences (Dharan, Nepal)
  • Katerina Mougkou, MD, National Kapodistrian University, Athens School of Medicine (Athens, Greece)
  • Chimanjita Phukan, MD, Gauhati Medical College & Hospital (Guwahati, India)
  • Peter Pindan, National Department of Health Port Moresby, Papua New Guinea)
  • Maria Inés Staneloni, MD, Hospital Italiano de Buenos Aires (Buenos Aires, Argentina)
  • Cheng Ying, MD, PhD, China CDC (Beiing, China)

2012 Delegation

  • Aziz O. Abdallah, MD, MS, HIVMAN, University Research Corporation, LLC, (Windhoek, Namibia)
  • Pierre Abi Hanna, MD, MPH, Rafik Hariri University Hospital (Beirut, Lebanon)
  • Martha I. Alvarez Larrañaga, MD, MPH, Fundacion Cardioinfantil IC (Cundinamarca, Colombia)
  • Hitoshi Honda, MD, Teine Keijinkai Medical Center (Hokkaido, Japan)
  • Ali Miraj Khan, MBBS, International Centre for Diarrhoeal Disease Research, (Dhaka, Bangledesh) (deceased)
  • Hong Bin Kim, MD, Seoul National University Bundang Hospital (Seongnam, Korea)
  • Admasu T. Mamuye, MD, Addis Ababa University School of Medicine (Addis Ababa, Ethiopia)
  • Maria Alejandra Marcotti, MD, Clinica Alemana (Santiago, Chile)
  • Joseph Ogirima Ovosi, MBBS, Ahmadu Bello University Teaching Hospital (Kaduna, Northern Nigeria)
  • Tamer Saied, MD, MSC, U.S. Naval Medical Research (Cairo, Egypt)
  • Sung Won Yoon Chang, RN, PhD, IC, Samsung Medical Center (Seoul, Korea)

Dr. Khan passed away shortly after submitting his application, and SHEA did not learn of his passing until after awarding him this honor.  For 2012, Dr. Khan has been named an honorary International Ambassador.

2011 Delegation

  • Romanee Chaiwarith, MD, MHS, Chiang Mai University (Chiang Mai, Thailand)
  • Matan Cohen, MD, MPH, Hadassah-Hebrew University Medical Center (Jerusalem, Israel)
  • Mirian Dalben, MD, Universidade de Sao Paulo (Sao Paulo, Brazil)
  • Arti Kapil, MD, All India Institute of Medical Sciences (New Delhi, India)
  • Vikas Manchanda, MD, Chacha Nehru Bal Chikitsalaya (Delhi, India)
  • Rose Ngugi, RN, The Nairobi Hospital (Nairobi, Kenya)
  • Michael Oji, MBBS, Lagoon Hospital (Lagos, Nigeria)
  • Andrea Restrepo, MD, Hospital Pablo Tobon Uribe (Antioguia, Colombia)
  • Le Anh Thu, MD, PhD, Cho Ray Hospital (Ho Chi Minh, Vietnam)
  • Zhiyong Zong, PhD, MBBS, MS, West China Hospital (Sichuan, China)

2010 Delegation

  • Carlos Alvarez, MD, MSc, Hospital Universitario San Ignacio, Javeriana University  (Bogota, Colombia)
  • Wu Anhua, MD, PhD, Xiangya Hospital,Central South University (Hunan, China)
  • Susan Anumo Otieno, MPH, RN, Kenyatta University (Nairobi, Kenya)
  • Anita Arora, MD, MBBS, Fortis Escorts Heart Institute and Research Centre (Delhi, India)
  • Sheila Donlon, MD, Health Protection Surveillnace Centre (Cavan Town, Ireland)
  • Nordiah Jalil, MD, MSc, Universiti Kebangsaan Malaysia Medical Centre (Kuala Lumpur, Malaysia)
  • Silma Pinheiro, PhD, RN, MSc, Federal University of Minas Gerais (Minas Gerias, Brazil) (deceased)
  • Josephine Anne Navoa-Ng, MD, St. Luke's Medical Center (Manila, Philippines)
  • Sanjeev Singh, MD, Amrita Institute of Medical Sciences (Kerala, India)
  • Graciela Solache-Alcaraz, MD, Hospital General de México, OD, Health Ministry (Mexico City, Mexico)

2009 Delegation

  • María Cristina Ajenjo, MD, Internal Medicine, Pontificia Universidad Católica de Chile (Santiago, Chile)
  • Ícaro Boszczowski, MD, MSc, Hospital das Clínicas University of Sao Paulo (Sao Paulo, Brazil)
  • Ana Correa, MD, Hospital Pablo Tobon Uribe (Antioquia, Colombia
  • Bijie Hu, MD, Zhongshan Hospital of Fudan University (Shanghai, China)
  • Nongyao Kasatpibal, PhD, RN, MNS, Chaing Mai University (Chaing Mai, Thailand)
  • Linus Ndegwa, MPHE, HCS, PGD Ophth, Centres for Disease Control- CDC (Nairobi, Kenya)
  • Anand Manoharan, PhD, MPH, MSc, Christian Medical College & Hospital (Tamil Nadu, India)
  • Alex Owusu-Ofori, MD, Komfo Anokye Teaching Hospital (Kumasi, Ghana)
  • Akihiko Saitoh, MD, PhD, FAAP, National Center for Child Health and Development Director (Tokyo, Japan)
  • Sharmila Sengupta, MD, SRL Lab, Fortis Hospital (Delhi, India)
  • Mohammed Youbi, MD, Ministry of Health (Rabat, Morocco)